AstraZeneca Launches Four New Collaborations to Feature CRISPR in R&D

Jan 29, 2015

|

NEW YORK (GenomeWeb) – AstraZeneca today announced four collaborations to implement CRISPR/cas9 genome editing technology across its drug discovery platform.

The firm's collaborators are the Wellcome Trust Sanger Institute, The Innovative Genomics Initiative, Thermo Fisher Scientific, and the Broad and Whitehead Institutes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu